StockData
Adagio Medical Holdings, Inc. logo

Adagio Medical Holdings, Inc. (ADGM) stock

ADGMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.12+0.02 (+21.21%)

Close on Oct 19, 2026Market cap $99.99KP/E –Yield –

Adagio Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Adagio Medical's free cash flow for the twelve months ending Sep 30, 2026 was -$17.65M. For fiscal 2025 it was -$19.39M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.39M–
FY2023Dec 31, 2023-$25.99M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$4.61M–
Q2 FY2026Jun 30, 2026-$5.27M–
Q1 FY2026Mar 31, 2026-$4.13M–
Q4 FY2025Dec 31, 2025-$3.65M–
Q3 FY2025Sep 30, 2025-$3.53M–
Q2 FY2025Jun 30, 2025-$4.67M–
Q1 FY2025Mar 31, 2025-$7.55M–
Q2 FY2024Jun 30, 2024-$7.12M–
Q1 FY2024Mar 31, 2024-$6.90M–
Q4 FY2023Dec 31, 2023-$7.11M–

More Adagio Medical figures

See a number that looks wrong?